MEDTRONIC TRANSCATHETER VALVE
Report
- Report Number
- 2025587-2021-03832
- Event Type
- Injury
- Date Received
- December 22, 2021
- Date of Event
- February 10, 2020
- Report Date
- December 22, 2021
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TU
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CITATION: ALPASLAN ET AL. NEW RISK FACTORS IN DETERMINING LONG-TERM MORTALITY IN PATIENTS UNDERGOING TAVI: CAN THE CONVENTIONAL RISK SCORES BE USED AS A LONG-TERM MORTALITY PREDICTOR? (B)(6). (B)(6) 2020; 78(3):219-226. DOI: (B)(4). EPUB(B)(4), (B)(6) 2020. EARLIEST DATE OF PUBLISH USED FOR DATE OF EVENT. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING NEW RISK FACTORS IN DETERMINING LONG-TERM MORTALITY IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI). ALL DATA WERE COLLECTED FROM MULTIPLE CENTERS BETWEEN JUNE 2012 AND MARCH 2016. THE STUDY POPULATION INCLUDED 121 PATIENTS (PREDOMINANTLY FEMALE, MEAN (B)(6). MULTIPLE MANUFACTURER¿S DEVICES WERE IMPLANTED IN THE STUDY POPULATION. EIGHTY-EIGHT PATIENTS WERE IMPLANTED WITH A MEDTRONIC COREVALVE OR EVOLUT R BIOPROSTHETIC VALVE (UNIQUE DEVICE IDENTIFIER NUMBERS NOT PROVIDED). AMONG ALL PATIENTS, TWO DEATHS OCCURRED IN-HOSPITAL AND 26 DEATHS OCCURRED DURING FOLLOW-UP. NO STATEMENT WAS MADE INDICATING A CAUSAL OR CONTRIBUTORY RELATIONSHIP BETWEEN MEDTRONIC PRODUCT AND THE DEATH(S). BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT WAS NOT DIRECTLY ASSOCIATED WITH THE DEATH(S). AMONG ALL PATIENTS, ADVERSE EVENTS INCLUDED: VASCULAR COMPLICATION, CORONARY OBSTRUCTION, NEW LEFT BUNDLE BRANCH BLOCK (LBBB), MODERATE TO SEVERE PARAVALVULAR LEAK (PVL) OR AORTIC REGURGITATION (AR), ARRHYTHMIA REQUIRING PERMANENT PACEMAKER IMPLANT, STROKE, AND VENTRICULAR SEPTAL DEFECT. BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT MAY HAVE BEEN ASSOCIATED WITH THE ADVERSE EVENT(S). NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1961058 | MEDTRONIC TRANSCATHETER VALVE | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV | NPT | MEDTRONIC HEART VALVES DIVISION | MDT-TRANS VALVE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Female | Life Threatening| R |